These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10666082)
1. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Liu YH; Yang XP; Mehta D; Bulagannawar M; Scicli GM; Carretero OA Am J Physiol Heart Circ Physiol; 2000 Feb; 278(2):H507-14. PubMed ID: 10666082 [TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437 [TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin II type 2 receptors and kinins in the cardioprotective effect of angiotensin II type 1 receptor antagonists in rats with heart failure. Liu YH; Yang XP; Shesely EG; Sankey SS; Carretero OA J Am Coll Cardiol; 2004 Apr; 43(8):1473-80. PubMed ID: 15093886 [TBL] [Abstract][Full Text] [Related]
4. Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice. Yang XP; Liu YH; Mehta D; Cavasin MA; Shesely E; Xu J; Liu F; Carretero OA Circ Res; 2001 May; 88(10):1072-9. PubMed ID: 11375278 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model. Koch M; Bonaventura K; Spillmann F; Dendorfer A; Schultheiss HP; Tschöpe C Biol Chem; 2008 Jun; 389(6):719-23. PubMed ID: 18627293 [TBL] [Abstract][Full Text] [Related]
6. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Yang XP; Liu YH; Scicli GM; Webb CR; Carretero OA Hypertension; 1997 Sep; 30(3 Pt 2):735-40. PubMed ID: 9323015 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180 [TBL] [Abstract][Full Text] [Related]
8. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure. Cavasin MA; Yang XP; Liu YH; Mehta D; Karumanchi R; Bulagannawar M; Carretero OA J Cardiovasc Pharmacol; 2000 Oct; 36(4):472-80. PubMed ID: 11026648 [TBL] [Abstract][Full Text] [Related]
9. Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats. Rhaleb NE; Yang XP; Nanba M; Shesely EG; Carretero OA Hypertension; 2001 Jan; 37(1):121-128. PubMed ID: 11208766 [TBL] [Abstract][Full Text] [Related]
10. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576 [TBL] [Abstract][Full Text] [Related]
11. Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in rats. Ito H; Hayashi I; Izumi T; Majima M Br J Pharmacol; 2003 Jan; 138(1):225-33. PubMed ID: 12522094 [TBL] [Abstract][Full Text] [Related]
12. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues. Nolly H; Miatello R; Damiani MT; Abate CD Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545 [TBL] [Abstract][Full Text] [Related]
13. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811 [TBL] [Abstract][Full Text] [Related]
14. Effects of a neutral endopeptidase inhibitor, BP102, on the development of deoxycorticosterone acetate-salt hypertension in kininogen-deficient Brown Norway Katholiek rats. Nakajima S; Majima M; Ito H; Hayashi I; Yajima Y; Katori M Int J Tissue React; 1998; 20(2):45-56. PubMed ID: 9638501 [TBL] [Abstract][Full Text] [Related]
15. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies. Linz W; Wiemer G; Schölkens BA Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801 [TBL] [Abstract][Full Text] [Related]
16. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807 [TBL] [Abstract][Full Text] [Related]
17. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway. Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655 [TBL] [Abstract][Full Text] [Related]
18. The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice. Xu J; Carretero OA; Shesely EG; Rhaleb NE; Yang JJ; Bader M; Yang XP Exp Physiol; 2009 Mar; 94(3):322-9. PubMed ID: 19060116 [TBL] [Abstract][Full Text] [Related]
19. Kinins are implicated of the hypotensive effect of acidic fibroblast growth factor. Saenz de Tejada I; Carceller F; Fernandez A; Cuevas B; Ortes L; Giménez-Gallego G; Cuevas P Eur J Med Res; 1997 Jul; 2(7):302-4. PubMed ID: 9233905 [TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]